Michael Anthony Healy
Corporate Officer/Principal bei The University of Nottingham
Aktive Positionen von Michael Anthony Healy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Nottingham | Corporate Officer/Principal | 14.12.2009 | - |
Karriereverlauf von Michael Anthony Healy
Ehemalige bekannte Positionen von Michael Anthony Healy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Michael Anthony Healy
- Erfahrung
